Cardinal Health director granted 381-share equity award

Hall Patricia Hemingway reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 04/17/2026 - 07:26 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Hall Patricia Hemingway reported acquisition or exercise transactions in this Form 4 filing.

Cardinal Health director Patricia Hemingway Hall reported an equity award rather than an open-market trade. She received 381 Common Shares in the form of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026, at a reference price of $207.83 per share. Following this grant, she directly holds 28,645 Common Shares.

Insider Trade Summary

Grant/Award: 381 shares

Grant/Award 1 txn

Insider Hall Patricia Hemingway

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	381	$207.83	$79K

Holdings After Transaction: Common Shares — 28,645 shares (Direct)

Holdings Before and After: Common Shares, 28,264 to 28,645 shares (Direct)

Footnotes (2)

1. F1. Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026.
2. F2. Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board.

Key Figures

Equity grant size: 381 Common Shares Reference share price: $207.83 per share Shares held after grant: 28,645 Common Shares +2 more

5 metrics

Equity grant size 381 Common Shares RSU-related award to Patricia Hemingway Hall

Reference share price $207.83 per share Closing price on March 20, 2026 used for RSU grant

Shares held after grant 28,645 Common Shares Direct holdings following the reported transaction

Effective date of Chair role March 20, 2026 Date Patricia Hemingway Hall was elevated to Chair of the Board

Form 4 transaction date April 15, 2026 Date of reported non-derivative acquisition

Key Terms

RSUs, Chair of the Board, Common Shares, Form 4

4 terms

RSUs financial

"Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Chair of the Board financial

"her elevation to Chair of the Board, effective March 20, 2026"

Common Shares financial

"security_title": "Common Shares""

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cardinal Health (CAH) director Patricia Hemingway Hall report in this Form 4 filing?

Patricia Hemingway Hall reported receiving 381 Common Shares as an equity award. The grant is tied to additional RSUs she received when she was elevated to Chair of the Board, reflecting compensation rather than an open-market stock purchase or sale.

How many Cardinal Health (CAH) shares did Patricia Hemingway Hall hold after the reported transaction?

After the reported RSU-related grant of 381 Common Shares, Patricia Hemingway Hall directly held 28,645 Common Shares. This figure reflects her position immediately following the transaction disclosed in the Form 4 insider trading report for Cardinal Health.

What was the reference price used for Patricia Hemingway Hall’s Cardinal Health (CAH) RSU grant?

The RSU grant to Patricia Hemingway Hall used a reference price of $207.83 per share. According to the disclosure, this corresponds to the closing Cardinal Health share price on March 20, 2026, the date she was elevated to Chair of the Board.

Why did Patricia Hemingway Hall receive additional RSUs from Cardinal Health (CAH)?

Patricia Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board. The filing states that this appointment became effective March 20, 2026, and the equity award reflects compensation associated with her new leadership role.

Was Patricia Hemingway Hall’s Cardinal Health (CAH) Form 4 transaction a market purchase or sale?

The transaction reported was not a market purchase or sale. It was a grant of 381 Common Shares tied to additional RSUs awarded when she became Chair of the Board, representing compensation rather than a discretionary buy or sell in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hall Patricia Hemingway

(Last) (First) (Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN OHIO 43017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/15/2026		A		381	A(1)	$207.83(2)	28,645	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026.

2. Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board.

Remarks:

	/s/ Laura C. Dhaliwal, Attorney-in-fact	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)